Anthony J Japour - Net Worth and Insider Trading

Anthony J Japour Net Worth

The estimated net worth of Anthony J Japour is at least $1,260 dollars as of 2024-04-27. Anthony J Japour is the Director of OPKO Health Inc and owns about 1,000 shares of OPKO Health Inc (OPK) stock worth over $1,260. Details can be seen in Anthony J Japour's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anthony J Japour has not made any transactions after 2020-03-12 and currently still holds the listed stock(s).

Transaction Summary of Anthony J Japour

Anthony J Japour Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anthony J Japour owns 3 companies in total, including Cocrystal Pharma Inc (COCP) , OPKO Health Inc (OPK) , and Sanaby Health Acquisition Corp I (SANB) .

Click here to see the complete history of Anthony J Japour’s form 4 insider trades.

Insider Ownership Summary of Anthony J Japour

Ticker	Comapny	Transaction Date	Type of Owner
COCP	Cocrystal Pharma Inc	2019-04-04	director
OPK	OPKO Health Inc	2020-03-12	director
SANB	Sanaby Health Acquisition Corp I	2021-10-14	director

Anthony J Japour Latest Holdings Summary

Anthony J Japour currently owns a total of 1 stock. Anthony J Japour owns 1,000 shares of OPKO Health Inc (OPK) as of March 12, 2020, with a value of $1,260.

Latest Holdings of Anthony J Japour

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
OPK	OPKO Health Inc	2020-03-12	1,000	1.26	1,260

Holding Weightings of Anthony J Japour

Anthony J Japour Form 4 Trading Tracker

According to the SEC Form 4 filings, Anthony J Japour has made a total of 2 transactions in OPKO Health Inc (OPK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in OPKO Health Inc is the acquisition of 500 shares on March 12, 2020, which cost Anthony J Japour around $755.

Insider Trading History of Anthony J Japour

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anthony J Japour Trading Performance

GuruFocus tracks the stock performance after each of Anthony J Japour's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony J Japour is 63.68%. GuruFocus also compares Anthony J Japour's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony J Japour within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Anthony J Japour's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Anthony J Japour

Average Return

202.29%

Average return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-10.46	63.68	109.67	202.29	47.1	-6.12
Relative Return to S&P 500(%)	-8.12	50.39	84.81	159.3	21.72	-19.3

Anthony J Japour Ownership Network

Ownership Network List of Anthony J Japour

No Data

Ownership Network Relation of Anthony J Japour

Anthony J Japour Owned Company Details

What does Cocrystal Pharma Inc do?

Who are the key executives at Cocrystal Pharma Inc?

Anthony J Japour is the director of Cocrystal Pharma Inc. Other key executives at Cocrystal Pharma Inc include director & 10 percent owner Frost Phillip Md Et Al , director & 10 percent owner Raymond F Schinazi , and Interim CFO James Joseph Martin .

Cocrystal Pharma Inc (COCP) Insider Trades Summary

Over the past 18 months, Anthony J Japour made no insider transaction in Cocrystal Pharma Inc (COCP). Other recent insider transactions involving Cocrystal Pharma Inc (COCP) include a net purchase of 1,015,229 shares made by Frost Phillip Md Et Al ,

In summary, during the past 3 months, insiders sold 0 shares of Cocrystal Pharma Inc (COCP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cocrystal Pharma Inc (COCP) were sold and 1,015,229 shares were bought by its insiders, resulting in a net purchase of 1,015,229 shares.

Cocrystal Pharma Inc (COCP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cocrystal Pharma Inc Insider Transactions

No Available Data

What does OPKO Health Inc do?

Who are the key executives at OPKO Health Inc?

Anthony J Japour is the director of OPKO Health Inc. Other key executives at OPKO Health Inc include 10 percent owner Frost Phillip Md Et Al , director & Chief Innovation Officer Gary J. Nabel , and director & Vice Chairman and President Elias A. Zerhouni .

OPKO Health Inc (OPK) Insider Trades Summary

Over the past 18 months, Anthony J Japour made no insider transaction in OPKO Health Inc (OPK). Other recent insider transactions involving OPKO Health Inc (OPK) include a net purchase of 12,636,531 shares made by Frost Phillip Md Et Al , a net purchase of 400,010 shares made by Hsiao Jane Ph D , and a net purchase of 676,429 shares made by Gary J. Nabel .

In summary, during the past 3 months, insiders sold 0 shares of OPKO Health Inc (OPK) in total and bought 5,130,000 shares, with a net purchase of 5,130,000 shares. During the past 18 months, 0 shares of OPKO Health Inc (OPK) were sold and 14,388,270 shares were bought by its insiders, resulting in a net purchase of 14,388,270 shares.

OPKO Health Inc (OPK)'s detailed insider trading history can be found in Insider Trading Tracker table.

OPKO Health Inc Insider Transactions

No Available Data

What does Sanaby Health Acquisition Corp I do?

Who are the key executives at Sanaby Health Acquisition Corp I?

Anthony J Japour is the director of Sanaby Health Acquisition Corp I. Other key executives at Sanaby Health Acquisition Corp I include 10 percent owner Sanaby Health Sponsor I Llc , director & Chief Executive Officer Sandra Shpilberg , and director & CFO; COO; Secretary Mark Joing .

Sanaby Health Acquisition Corp I (SANB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sanaby Health Acquisition Corp I (SANB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sanaby Health Acquisition Corp I (SANB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sanaby Health Acquisition Corp I (SANB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sanaby Health Acquisition Corp I Insider Transactions

No Available Data

Anthony J Japour Mailing Address

Above is the net worth, insider trading, and ownership report for Anthony J Japour. You might contact Anthony J Japour via mailing address: 19805 N. Creek Parkway, Bothell Wa 98011.

Discussions on Anthony J Japour

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.